High levels of FFAs are accompanied by defective insulin signaling and beta‐cell dysfunction (Sonnweber et al., 2018), and type 2 diabetes is often accompanied by elevated plasma FFAs (Sobczak & Blindauer, 2019). Here, INS is linked to type 2 diabetes mellitus.